popular women's health searches
women's news and features
Cookies always calling your name? Here's how you can stop your sugar cravings once and for all.
Top Stories
- FDA OKs New Drug for Heavy Menstrual Bleeding
- Too Many Mastectomies? Maybe Not
- Slideshow: Screening Tests Every Woman Needs
- Asthma in Women: Impact of Hormones
- What Do Your Teeth Say About Your Health?
- Pets and a Clean House: Can They Coexist?
community views & insights
Stop Having the Same Fight
Break the habit and have a happier marriage.Skin Saboteurs
Conquer your complexion imperfections.Boards
More Boards
- "Nervous about yeast infection treatment."
- "How do you know when your marriage is over?"
- "He has a large penis. Help!"
Blogs
More Community
- "My Female Organs Are Falling Down"
- Pam Peeke: Shake Up Your Fat Cells
- Pregnant? Why You Should Get Vaccinated
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

